Cargando…

MPS status report no. 222 Period 17.9.19 73 to 20.10.19 73 (Weeks 39-42)

Detalles Bibliográficos
Autor principal:	Frammery, B
Lenguaje:	fre
Publicado:	1973
Materias:	Accelerators and Storage Rings
Acceso en línea:	http://cds.cern.ch/record/2829070

Ejemplares similares

Mps status report no. 217: Period 23.4.1973 to 19.5.1973 (Weeks 17 - 20)
por: Frammery, B
Publicado: (1973)

MPS Status Report No. 73: Période du 1er au 31 décembre 1964
por: Henny, L
Publicado: (1965)

MPS status report no. 241: Period 24.9.1975-18.10.1975 (Weeks 39, 40, 41, 42)
por: Asboe-Hansen, P
Publicado: (1975)

MPS status report no. 216: Period 26.3.1973 to 19.4.1973 (Weeks 13 - 16)
por: Frammery, B
Publicado: (1973)

MPS STATUS REPORT No. 221: Period 20.8.1973 to 15.9.1973 (Weeks 34-37)
por: Frammery, B
Publicado: (1973)

PS MD Studies Report No 19: Period September 24 - October 20, 1973 (Weeks 39-42)
por: Barbalat, O, et al.
Publicado: (1973)

Section droite 73 (MPS-3A79-100-0A)
por: Lebeau, M
Publicado: (1971)

Mps status report No. 231: Period September 2-28, 1974 (Weeks 36-39)
por: Asboe-Hansen, P
Publicado: (1974)

Defining the CD39/CD73 Axis in SARS-CoV-2 Infection: The CD73(-) Phenotype Identifies Polyfunctional Cytotoxic Lymphocytes
por: Ahmadi, Parimah, et al.
Publicado: (2020)

MPS status report no. 215: Period 21.2.1973 to 24.3.1973 (Weeks 8 - 12)
por: Frammery, B
Publicado: (1973)

MPS status report no. 219: Period 18.6.1973 to 14.7.1973 (Weeks 25 - 28)
por: Frammery, B
Publicado: (1973)

Mps status report no. 220: Period 16.7.1973 to 18.8.1973 (Weeks 29-32)
por: Frammery, B
Publicado: (1973)

Mps status report no. 218: Period 21.5.1973 to 16.6.1973 (Weeks 21 - 24)
por: Frammery, B
Publicado: (1973)

Mps status report no. 232: Period October 1-27, 1974 (Weeks 40-42)
por: Asboe-Hansen, P
Publicado: (1974)

Low expression of CD39 and CD73 genes in centenarians compared with octogenarians
por: Crooke, Almudena, et al.
Publicado: (2017)

Monitoring and characterizing soluble and membrane-bound ectonucleotidases CD73 and CD39
por: Goueli, Said A., et al.
Publicado: (2019)

CD39 and CD73 as Promising Therapeutic Targets: What Could Be the Limitations?
por: Battastini, Ana Maria Oliveira, et al.
Publicado: (2021)

CD39/CD73/A2AR pathway and cancer immunotherapy
por: Xia, Chenglai, et al.
Publicado: (2023)

The ectonucleotidases CD39 and CD73 on T cells: The new pillar of hematological malignancy
por: Jiang, Xuan, et al.
Publicado: (2023)

Exploring CD39 and CD73 Expression as Potential Biomarkers in Prostate Cancer
por: Gardani, Carla Fernanda Furtado, et al.
Publicado: (2023)

Datafair 73
por: Collective
Publicado: (1973)

Relative expression of TAp73 and ΔNp73 isoforms
por: Conforti, Franco, et al.
Publicado: (2012)

High Expression of Ecto-Nucleotidases CD39 and CD73 in Human Endometrial Tumors
por: Aliagas, Elisabet, et al.
Publicado: (2014)

The Role of Ectonucleotidases CD39 and CD73 and Adenosine Signaling in Solid Organ Transplantation
por: Roberts, Veena, et al.
Publicado: (2014)

Unifying the p73 knockout phenotypes: TAp73 orchestrates multiciliogenesis
por: Napoli, Marco, et al.
Publicado: (2016)

Memorandum: proposal CERN/SPSC/74-73/P 17
por: Buude, R
Publicado: (1974)

SIGME Symposium 73
por: Association for Computing Machinery. New York
Publicado: (1973)

Nobel symposium 73
por: Lundqvist, S, et al.
Publicado: (1988)

Nélaton, 1807–73
Publicado: (1873)

Contents of Volume 73
Publicado: (2007)

Enhanced expression of CD39 and CD73 on T cells in the regulation of anti-tumor immune responses
por: Shevchenko, Ivan, et al.
Publicado: (2020)

Booster operation committee no 73: compte rendu de la réunion du 27 avril 1983
por: Frammery, B
Publicado: (1983)

Periodicity in 17 Background Rates, Run 373M, 26.10.73, 11 GeV/c
por: Guignard, G
Publicado: (1973)

Nucleotide Analog ARL67156 as a Lead Structure for the Development of CD39 and Dual CD39/CD73 Ectonucleotidase Inhibitors
por: Schäkel, Laura, et al.
Publicado: (2020)

Epigenetic modification in the expression of p73 p73 - epigenetic target for anticancer therapy
por: Naseer, Faiza, et al.
Publicado: (2019)

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
por: Deaglio, Silvia, et al.
Publicado: (2007)

The adenosine generating enzymes CD39/CD73 control microglial processes ramification in the mouse brain
por: Matyash, Marina, et al.
Publicado: (2017)

Course CERN 73 - 74
Publicado: (1974)

Zona Atzacan, sismo 73 :
por: Luna Rincón, Antonio
Publicado: (1974)

73 circuitos electrónicos prácticos
por: Penfold, R. A.
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_20r0tiof6gkebvnica4l8fgiku